BIOMAT Database Logo BIOMAT Database Logo

Identification of angiotensin II receptor subtypes. 1989

A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Medical Products Department E. I. du Pont de Nemours & Company Wilmington, Delaware 19800-0400.

We have demonstrated the existence of two distinct subtypes of the angiotensin II receptor in the rat adrenal gland using radioligand binding and tissue section autoradiography. The identification of the subtypes was made possible by the discovery of two structurally dissimilar, nonpeptide compounds, DuP 753 and EXP655, that show reciprocal selectivity for the two subtypes. In the rat adrenal cortex, DuP 753 inhibited 80% of the total AII binding with an IC50 value on the sensitive sites of 2 x 10(-8) M, while EXP655 displaced only 20%. In the rat adrenal medulla, EXP655 gave 90% inhibition of AII binding with an IC50 value of 3.0 x 10(-8) M, while DuP 753 was essentially inactive. The combination of the two compounds completely inhibited AII binding in both tissues.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008861 Microsomes Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Microsome
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D000302 Adrenal Cortex The outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones (outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS) with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN. Cortex, Adrenal
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D000313 Adrenal Medulla The inner portion of the adrenal gland. Derived from ECTODERM, adrenal medulla consists mainly of CHROMAFFIN CELLS that produces and stores a number of NEUROTRANSMITTERS, mainly adrenaline (EPINEPHRINE) and NOREPINEPHRINE. The activity of the adrenal medulla is regulated by the SYMPATHETIC NERVOUS SYSTEM. Adrenal Medullas,Medulla, Adrenal,Medullas, Adrenal
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Identification of angiotensin II receptor subtypes in human brain.
October 1991, Neuroreport,
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Identification and characterisation of angiotensin II receptor subtypes in human brain.
January 1993, European journal of pharmacology,
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells.
June 1991, Hypertension (Dallas, Tex. : 1979),
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium.
November 1990, Biochemical and biophysical research communications,
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Identification of two subtypes in the rat type I angiotensin II receptor.
February 1992, FEBS letters,
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Characterization of glomerular angiotensin II receptor subtypes.
January 1992, Receptor,
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Angiotensin II receptor subtypes in the kidney.
April 1993, Journal of the American Society of Nephrology : JASN,
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Angiotensin II receptor subtypes and cardiac function.
December 1994, European heart journal,
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Angiotensin II receptor subtypes in rat brain.
February 1991, Clinical and experimental pharmacology & physiology,
A T Chiu, and W F Herblin, and D E McCall, and R J Ardecky, and D J Carini, and J V Duncia, and L J Pease, and P C Wong, and R R Wexler, and A L Johnson
Characterization of angiotensin II-receptor subtypes in podocytes.
November 2003, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!